NXC-201 (formerly HBI0101) Multiple Myeloma

NCT04720313 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Dose Escalation and Safety

Interventions

DRUG: NXC-201 (formerly HBI0101)

Sponsor

Hadassah Medical Organization

Collaborators

[object Object]